Central and peripheral nervous system toxicity of common chemotherapeutic agents Chrissa SiokaAthanassios P. Kyritsis Mini Review 25 November 2008 Pages: 761 - 767
Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79 Teresa Kosakowska-CholodyWieslaw M. CholodyBrian I. Carr Original Article 19 July 2008 Pages: 769 - 778
Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature Gil Bar-SelaNissim Haim Original Article 19 July 2008 Pages: 779 - 782
Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival Kristen FosterYong WangCynthia Wright Original Article 19 July 2008 Pages: 783 - 791
Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551 Nancy L. BartlettJeffrey L. JohnsonFor the Cancer and Leukemia Group B Original Article 23 July 2008 Pages: 793 - 798
A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin Kurt Van der SpeetenO. A. StuartP. H. Sugarbaker Original Article 25 July 2008 Pages: 799 - 805
Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines Scott M. StoegerKenneth H. Cowan Original Article 26 July 2008 Pages: 807 - 818
A multiple-center phase II study of biweekly oxaliplatin and tegafur–uracil/leucovorin for chemonaive patients with advanced gastric cancer Jen-Shi ChenKun-Ming RauRuey-Ho Kao Original Article Open access 29 July 2008 Pages: 819 - 825
A model-based approach to the in vitro evaluation of anticancer activity Francesca Del BeneMassimiliano GermaniMaurizio Rocchetti Original Article 29 July 2008 Pages: 827 - 836
Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-β-d-ribo-pentofuranosyl)cytosine Tomoharu NaitoTatsushi YokogawaHye-Sook Kim Original Article 31 July 2008 Pages: 837 - 850
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma Joanna M. BrellSmitha S. KrishnamurthiScot C. Remick Original Article 01 August 2008 Pages: 851 - 857
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804 Richard M. StoneKathleen A. Donohuefor the Cancer and Leukemia Group B Original Article 01 August 2008 Pages: 859 - 864
Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer Tomo OsakoYoshinori ItoKiyohiko Hatake Original Article 01 August 2008 Pages: 865 - 871
Protective effect of aged garlic extract (AGE) on the apoptosis of intestinal epithelial cells caused by methotrexate Tiesong LiKousei ItoToshiharu Horie Original Article 02 August 2008 Pages: 873 - 880
The Werner’s syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds Federico InnocentiSnezana MirkovMark J. Ratain Original Article 02 August 2008 Pages: 881 - 887
Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerases Andrew G. JobsonElaine WillmoreCaroline A. Austin Original Article 05 August 2008 Pages: 889 - 901
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors Claire F. VerschraegenKeith SkubitzFred B. Oldham Original Article 06 August 2008 Pages: 903 - 910
The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population Zhao-Hui HuangDong HuaLi-Hua Li Original Article 15 August 2008 Pages: 911 - 918
Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials Hei-Cheul JeungSun Young RhaHyun Cheol Chung Original Article 20 August 2008 Pages: 919 - 927
A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma Ji Eun UhmJoon Oh ParkHo Yeong Lim Original Article 23 August 2008 Pages: 929 - 935
Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer Mario CamponeMaria Blasinska-MorawiecMaud Brandely Original Article 27 August 2008 Pages: 937 - 943
A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy Janet S. GrahamStephen FalkT. R. Jeffry Evans Clinical Trial Report 25 July 2008 Pages: 945 - 952
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial Sibylle LoiblCaroline MurmannGunter von Minckwitz Clinical Trial Report 21 August 2008 Pages: 953 - 958
Intracellular disposition of fludarabine triphosphate in human natural killer cells Erica L. WoodahlJoanne WangJeannine S. McCune Short Communication 10 September 2008 Pages: 959 - 964
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer Lorenzo FornaroG. MasiA. Falcone Short Communication 07 October 2008 Pages: 965 - 969
Acute hepatic failure following monotherapy with sunitinib for ovarian cancer A. TaranA. IgnatovJ. Bischoff Letter to the Editor 21 August 2008 Pages: 971 - 972